Home › Targets › CD276

CD276 (1 companies · 2 programs)

Companies with an active program directed at CD276.

Aktis Oncology, Inc. AKTS

[225Ac]Ac-AKY-2519 — Prostate Cancer Phase 1
[225Ac]Ac-AKY-2519 — Non-Small Cell Lung Cancer Phase 1